
Journal of Medicinal Chemistry p. 357 - 366 (1987)
Update date:2022-08-04
Topics:
Lunt, Edward
Newton, Christopher G.
Smith, Christopher
Stevens, Graham P.
Stevens, Malcolm F. G.
et al.
The systematic variation of the potent antitumor agent mitozolomide (1) is extended to cover alteration of substituents at position 6 and 8 and to change the imidazo<5,1-d>-1,2,3,5-tetrazinone (6) skeleton to the isomeric pyrazolo<5,1-d>-1,2,3,5-tetrazino
View MoreShaanxi Sinuote Biotech Co.,Ltd
Contact:+86-29-68859685
Address:No 18,Taiyuan Road ,Xi'an city ,China
Nanjing Chemlin Chemical Co., Ltd.
website:http://www.echemlin.cn
Contact:+86-25-83697070
Address:Rm.902 Longyin Plaza, No. 217 Zhongshan Rd.(N) Nanjing 210009,China
Beijing ZhongDaXinHe Chemical Product Co.,Ltd(expird)
Contact:010-52876516
Address:tongzhoubeiyuan
Hubei Honch Pharmaceutical Co.,Ltd
Contact:86-713-7222018
Address:Li Shizhen Pharmaceutical Industry park, Qichun County, Hubei Province,China
Contact:+86-21-38122007
Address:2, Lane 1123, Kangqiao Road, Pudong New Area, Shanghai
Doi:10.1021/acs.orglett.7b03509
(2018)Doi:10.1021/ja00328a031
(1984)Doi:10.1021/ol061123c
(2006)Doi:10.1016/0040-4039(91)80043-6
(1991)Doi:10.1039/b605498f
(2006)Doi:10.1007/BF00515636
(1984)